Baxter SA

Lessines, BelgiumFEI 3005468265

Baxter SA is a drug establishment in Lessines, Belgium, registered with the US FDA under FEI 3005468265. Its registered operations are: Analytical testing, Labelling, Drug manufacture, Packaging, Sterilisation. 9 EU/UK GMP certificates are matched to this site, 7 inspected within the last three years.

Sources: FDA Drug Establishments Current Registration Site (checked 2 Nov 2026); EudraGMDP; MHRA GMDP. Methodology

Registered operations

Business operations this establishment declares in its FDA registration. Registration is not an approval and says nothing about EU or UK GMP status.

Analytical testingLabellingDrug manufacturePackagingSterilisation

GMP documents matched to this site (9)

DocumentAuthorityInspectionSource
BE/GMP/2025/140
GMP certificate
Competent authority of Belgium3 Oct 2025
within 3-year review window
EudraGMDP
BE/GMP/2025/139
GMP certificate
Competent authority of Belgium3 Oct 2025
within 3-year review window
EudraGMDP
BE/GMP/2024/125
GMP certificate
Competent authority of Belgium14 Jun 2024
within 3-year review window
EudraGMDP
BE/GMP/2024/126
GMP certificate
Competent authority of Belgium14 Jun 2024
within 3-year review window
EudraGMDP
BE/GMP/2024/094
GMP certificate
Competent authority of Belgium14 Jun 2024
within 3-year review window
EudraGMDP
BE/GMP/2023/104
GMP certificate
Competent authority of Belgium17 Nov 2023
within 3-year review window
EudraGMDP
BE/GMP/2023/105
GMP certificate
Competent authority of Belgium17 Nov 2023
within 3-year review window
EudraGMDP
BE/GMP/2021/147
GMP certificate
Competent authority of Belgium6 Oct 2021
outside 3-year review window
EudraGMDP
BE/GMP/2020/127
GMP certificate
Competent authority of Belgium14 Dec 2020
outside 3-year review window
EudraGMDP

A GMP document is matched to this site when its address names the site's street and its city or postcode. In our latest internal review 59 of 60 sampled matches were the right site (not yet independently reviewed; measured match quality). Check the certificate's own address before relying on it. The three-year review window is the EMA guideline default after an inspection, not an official expiry date.

What this page does not show

  • Which substances are made here: DMFs and CEPs are filed by organisations, not sites, so we do not link substances to this site.
  • Capacity, scale, price or current availability: no regulator publishes these.
  • FDA inspection classifications for this site, which are not yet linked.

Other sites registered by the same company